Order Article Reprints

Graziano F, Fischer NW, Bagaloni I, Di Bartolomeo M, Lonardi S, Vincenzi B, Perrone G, Fornaro L, Ongaro E, Aprile G, et al. TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy. Cancers. 2020; 12(8):2049. https://doi.org/10.3390/cancers12082049

Graziano, Francesco, Nicholas W. Fischer, Irene Bagaloni, Maria Di Bartolomeo, Sara Lonardi, Bruno Vincenzi, Giuseppe Perrone, Lorenzo Fornaro, Elena Ongaro, Giuseppe Aprile, and et al. 2020. "TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy" Cancers 12, no. 8: 2049. https://doi.org/10.3390/cancers12082049

Graziano, F., Fischer, N. W., Bagaloni, I., Di Bartolomeo, M., Lonardi, S., Vincenzi, B., Perrone, G., Fornaro, L., Ongaro, E., Aprile, G., Bisonni, R., Prisciandaro, M., Malkin, D., Gariépy, J., Fassan, M., Loupakis, F., Sarti, D., Del Prete, M., Catalano, V., ... Ruzzo, A. (2020). TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy. Cancers, 12(8), 2049. https://doi.org/10.3390/cancers12082049